Fennec Pharmaceuticals Inc
SWB:RV41
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
SWB:RV41
|
US |
|
Ford Motor Co
NYSE:F
|
US |
|
Telos Corp
NASDAQ:TLS
|
US |
|
W
|
Wacker Neuson SE
XMUN:WAC
|
DE |
|
P
|
Public Storage
SWB:PUP
|
US |
|
Logitech International SA
F:LTEC
|
CH |
|
F
|
Fresnillo PLC
DUS:FNL
|
MX |
|
Concurrent Technologies PLC
F:FJV
|
UK |
|
C
|
Cintas Corp
SWB:CIT
|
US |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
M
|
Matas A/S
SWB:1MTA
|
DK |
|
S
|
Schroders PLC
F:PYX
|
UK |
|
G
|
Grifols SA
MAD:GRF.P
|
ES |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RV41 is 13.51 EUR with a low forecast of 11.17 EUR and a high forecast of 16.08 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
13.51
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 13.51 EUR with a low forecast of 11.17 EUR and a high forecast of 16.08 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Revenue over the next 8 years is 24%.
What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
